Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Røder

Showing results (1-10 of 169) with videos related to

Pageof 17
Sort By:
Danish Medical Journal|December 21, 2013
Radical prostatectomy for clinically localised prostate cancer at Rigshospitalet 1995-2011 - an analysis of surgical and oncological outcomeMartin Andreas Røder
Ugeskrift for Laeger|November 13, 2018
[Prostate cancer surgery]Martin Andreas Røder, Peter Iversen
Urology|March 9, 2022
Reply to LetterMaja Vejlgaard, Martin Andreas Røder
Ugeskrift for Laeger|January 5, 2013
[Radical prostatectomy in patients with advanced prostate cancer]Martin Andreas Røder, Peter Iversen
Danish Medical Journal|October 24, 2025
Pro and con for systematic screening for prostate cancer in Denmark - a review articleSigne Benzon Larsen, Andreas Røder
BJU International|November 10, 2022
Case of the Month from Rigshospitalet, Copenhagen, Denmark: unexplained gross haematuriaTorben Kjaer Nielsen, Martin Andreas Røder
European Urology Oncology|December 15, 2024
Re: Julien Anract, Clément Klein, Ugo Pinar, Morgan Rouprêt, Nicolas Barry Delongchamps, Grégoire Robert. Incidental Prostate Cancer in Patients Undergoing Surgery for Benign Prostatic Hyperplasia: A Predictive Model. Eur Urol Oncol. 2025;8:145-51Riccardo Leni, Andreas Røder, Hein V Stroomberg
European Urology|May 15, 2024
Re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003Hein V Stroomberg, Klaus Brasso, Andreas Røder
Prostate Cancer and Prostatic Diseases|December 9, 2022
Fact, overdiagnosis cannot be evaluated by comparing histological grading of prostate biopsy to prostatectomy specimenHein Vincent Stroomberg, Klaus Brasso, Andreas Røder
JAMA Oncology|October 13, 2022
Association of 5α-Reductase Inhibitor Use With Prostate Cancer-Specific MortalityHein V Stroomberg, Klaus Brasso, Andreas Røder
Pageof 17

Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
Danish Medical Journal|December 21, 2013
Radical prostatectomy for clinically localised prostate cancer at Rigshospitalet 1995-2011 - an analysis of surgical and oncological outcomeMartin Andreas Røder
Ugeskrift for Laeger|November 13, 2018
[Prostate cancer surgery]Martin Andreas Røder, Peter Iversen
Urology|March 9, 2022
Reply to LetterMaja Vejlgaard, Martin Andreas Røder
Ugeskrift for Laeger|January 5, 2013
[Radical prostatectomy in patients with advanced prostate cancer]Martin Andreas Røder, Peter Iversen
Danish Medical Journal|October 24, 2025
Pro and con for systematic screening for prostate cancer in Denmark - a review articleSigne Benzon Larsen, Andreas Røder
BJU International|November 10, 2022
Case of the Month from Rigshospitalet, Copenhagen, Denmark: unexplained gross haematuriaTorben Kjaer Nielsen, Martin Andreas Røder
European Urology Oncology|December 15, 2024
Re: Julien Anract, Clément Klein, Ugo Pinar, Morgan Rouprêt, Nicolas Barry Delongchamps, Grégoire Robert. Incidental Prostate Cancer in Patients Undergoing Surgery for Benign Prostatic Hyperplasia: A Predictive Model. Eur Urol Oncol. 2025;8:145-51Riccardo Leni, Andreas Røder, Hein V Stroomberg
European Urology|May 15, 2024
Re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003Hein V Stroomberg, Klaus Brasso, Andreas Røder
Prostate Cancer and Prostatic Diseases|December 9, 2022
Fact, overdiagnosis cannot be evaluated by comparing histological grading of prostate biopsy to prostatectomy specimenHein Vincent Stroomberg, Klaus Brasso, Andreas Røder
JAMA Oncology|October 13, 2022
Association of 5α-Reductase Inhibitor Use With Prostate Cancer-Specific MortalityHein V Stroomberg, Klaus Brasso, Andreas Røder
Pageof 17